RxDoctor Payments Data

Lyndi Forrest, APRN

Family · Shelby, NCNPI 1801990593

Payments from drug & device makers

$397in general payments, 2019–2025

Across 19 payments — averaging $20.88 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Medtronic$89
  • AbbVie$85
  • Pfizer$79
  • AstraZeneca$46
  • Amgen$31
  • GSK$21
  • plus $46 from 3 others

What the payments were for

  • Food & beverage$397100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$397 in reported general payments places this provider in the 50th percentile of 4,522 family providers in North Carolina.

See all family providers in North Carolina

Medicare billing

Part B allowed, 2024
$66,897
Medicare patients
172
Services billed
872

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide78$90,316
MounjaroTirzepatide58$86,188
EliquisApixaban96$84,345
JanuviaSitagliptin Phosphate38$50,739
LinzessLinaclotide18$25,759
JardianceEmpagliflozin15$21,255
XareltoRivaroxaban16$13,893
Breztri AerosphereBudesonide/Glycopyr/Formoterol16$12,942
Repatha SureclickEvolocumab17$12,224
SymbicortBudesonide/Formoterol Fumarate17$6,321
Gabapentin240$5,002
Omeprazole330$4,978
SynthroidLevothyroxine Sodium37$4,476
Lantus SolostarInsulin Glargine,hum.Rec.Anlog34$4,016
Levothyroxine Sodium266$3,051

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskOzempic$16$90,31678 claims
Lilly USA, LLCMounjaro$14$86,18858 claims
PfizerEliquis, Paxlovid$79$85,774107 claims
AbbVieLinzess, Synthroid, Armour Thyroid$85$31,35672 claims
Boehringer IngelheimJardiance$16$21,25515 claims
AstraZenecaBreztri Aerosphere, Symbicort$46$19,26333 claims
GSKArnuity Ellipta$21$2,25811 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 50th percentile of 4,522 family providers in North Carolina.

Other family in Shelby

See the full list for North Carolina

Where these figures come from

Is this you, or does something look wrong? →